Rafieh Bagherifar

2 ta ish

Tabriz University of Medical Sciences

1. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide

   Atefeh Khodakarami, Mahsa Afsari Kashani, Atefeh Nazer +13

   MaqolaOAOchiq kirish20236 iqtibos

   ABIABI:AkademIndex/2026.other.130704

2. Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1

   Shiva Abolhasani, Armin Mahmoud Salehi Khesht, Atefeh Khodakarami +13

   Maqola20255 iqtibos

   ABIABI:AkademIndex/2026.other.826326